Suppliers and packagers for generic pharmaceutical drug: cholic acid

cholic acid

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Mirum	CHOLBAM	cholic acid	CAPSULE;ORAL	205750	NDA	Mirum Pharmaceuticals Inc.	79378-001-02	90 CAPSULE in 1 BOTTLE (79378-001-02)	2025-05-09
Mirum	CHOLBAM	cholic acid	CAPSULE;ORAL	205750	NDA	Mirum Pharmaceuticals Inc.	79378-002-02	90 CAPSULE in 1 BOTTLE (79378-002-02)	2025-05-09

Suppliers and packagers for generic pharmaceutical drug: cholic acid

Last updated: May 25, 2026

Suppliers for Cholic Acid (API and Intermediate Sources)

Cholic acid is widely sourced as a pharmaceutical active ingredient (API) and as a starting material for bile-acid formulations and research-grade chemicals. Supplier availability is split between (1) GMP API manufacturers for regulated markets and (2) fine-chemical and research suppliers for non-US/clinical uses. A practical sourcing plan requires mapping suppliers to intended use (commercial API vs. non-GMP), target jurisdiction (US/EU vs. ROW), and documentation package (DMF/CEP/CoA/traceability).

Who supplies cholic acid API for pharmaceutical use?

GMP API manufacturers and typical documentation

The most credible regulated-market suppliers are those that support at least one of the following: Drug Master File (DMF) for US, CEP (European certificate of suitability) for EU, or formal GMP manufacturing listings with COA and full traceability. Supplier shortlists for regulated cholic acid use should prioritize companies that can provide:

• DMF references or supported regulatory filings
• Batch COA with impurity profile
• Confirmation of compliance to ICH Q7/Q11 process controls
• Controls over bile-acid source variability (especially for naturally sourced cholic acid derivatives)

Supply-chain split: natural extraction vs. synthesis

Cholic acid is often sourced either via extraction/hydrolysis from animal bile fractions or via chemical modification routes. In procurement, this drives differences in impurity spectrum and change-control requirements:

• Natural/extraction routes tend to have broader impurity profiles tied to feedstock
• Synthetic purification routes tend to have tighter impurity control but higher cost and different regulatory expectations

What are the common global cholic acid suppliers (China, India, EU, US)?

China-based API supply landscape

China is the dominant cost and volume region for bile acids and steroidal APIs, including cholic acid. Typical supplier structure includes:

• API-focused manufacturers with multiple bile-acid SKUs
• Export-oriented fine-chemical plants with optional GMP grades
• Contract manufacturers that sell under a trading house

India-based supply landscape

India-based suppliers often support:

• DMF readiness and US-facing compliance packages
• Batch documentation standardized for western buyers
• Research-to-commercial bridging via grade escalation

EU and US supply

US/EU suppliers are more common in:

• Formulated products and distribution
• Specialty sourcing for regulated customers rather than raw, high-volume commodity-only supply
• Customer-specific impurity specifications and regulatory dossier support

How do suppliers for cholic acid compare by grade (USP, EP, BP) and use case?

Pharmaceutical grade vs. analytical grade

Procurement splits by grade requirements:

• USP/EP/BP grade cholic acid: requires pharmacopeial compliance plus impurity limits
• Analytical grade: suitable for methods validation and stability studies but not necessarily for clinical/commercial API use
• Research grade: lowest cost, often lacks full GMP batch documentation

Impurity profile and specifications

Key specification differences across suppliers:

• Known bile-acid related impurities (minor steroid acids)
• Residual solvents and heavy metals
• Water content and polymorphic form controls (where applicable)

Which suppliers offer cholic acid intermediates and bile-acid related chemicals?

Cholic acid is frequently bought alongside related bile acids used in development and manufacturing:

• Chenodeoxycholic acid
• Deoxycholic acid
• Ursodeoxycholic acid
• Lithocholic acid and derivatives

Suppliers that carry this broader bile-acid basket are often better positioned to support compatibility, impurity benchmarking, and commercial-scale supply continuity.

What regulatory documentation do cholic acid suppliers provide (DMF/CEP/GMP)?

US DMF and US-facing documentation

For US commercial supply, the high-value supplier is one that can support:

• A US DMF or reference capability
• Ability to support inspections or provide audit trails
• Consistent impurity and residual solvent compliance

EU CEP and QP release readiness

For EU, procurement targets suppliers with:

• CEP coverage for the relevant strength/grade
• Clear demarcation between API and intermediate steps
• Documentation for QP release workflows

What is the risk of supply disruption for cholic acid API?

Market concentration and feedstock sensitivity

Risks are typically concentrated in:

• Feedstock availability for naturally derived material
• Purification capacity for consistent impurity control
• Batch-to-batch change control from suppliers moving plants or processes

Mitigation via dual-sourcing

Best practice procurement relies on:

• Dual-source qualification (primary + backup)
• Locked specs and change-control notification terms
• Contractual supply commitments for long lead items

How many cholic acid API suppliers can meet pharmaceutical GMP requirements?

A typical outcome in regulated procurement is that only a subset of commodity-chemical suppliers can meet full GMP documentation expectations. The practical answer for qualification efforts is usually:

• A small number of suppliers able to provide DMF/CEP or equivalent dossier-grade support
• Multiple additional suppliers that may offer GMP but without regulatory dossier readiness
• Many additional suppliers that are suitable for research-only grades

What generic or formulation manufacturers need cholic acid sourcing support?

Cholic acid is used in:

• Bile-acid targeted formulations and excipient systems
• API research and formulation development
• Rare bile-acid related therapeutic research

Suppliers that support both API and related bile acids tend to reduce development friction by standardizing impurity profiles and analytical methods.

Key Takeaways

• Cholic acid sourcing splits into GMP API suppliers (regulated-grade) and non-GMP/research-grade vendors.
• The supplier shortlist for pharmaceutical use should be built around DMF/CEP readiness, GMP inspection history, and impurity specification control.
• Supplier risk is driven by feedstock sensitivity and purification capacity; dual-sourcing and locked specs reduce disruption risk.

FAQs

1. Do distributors of cholic acid qualify as GMP suppliers?
   Distributors often resell GMP-manufactured API; qualification depends on whether they provide full manufacturer documentation, CoA lineage, and regulatory dossier references.

2. Is cholic acid typically sold as a natural-extracted product or synthetic API?
   Both routes exist in the market; procurement should align to the supplier’s declared manufacturing route to manage impurity and change-control expectations.

3. What buyer documents matter most when selecting a cholic acid API supplier?
   DMF/CEP (or equivalent dossier support), full CoA with impurity profile, GMP manufacturing evidence, and residual solvent/water/heavy metal compliance.

4. How do suppliers control batch-to-batch variability for steroidal bile acids?
   Through feedstock control, in-process controls, and validated purification steps tied to tight impurity specifications.

5. What is the typical qualification timeline for a new cholic acid API supplier?
   Qualification depends on method transfer, impurity benchmarking, and regulatory documentation review, with lead times dominated by analytical comparability and audit readiness.

References

No sources were cited in the provided answer.